neurobehavioral

Study shows promising results of EEG-based brain training in helping adults with ADHD

by

Man­ag­ing atten­tion deficit dis­or­der by train­ing the brain (Sci­enceDai­ly):

Atten­tion Deficit Hyper­ac­tiv­i­ty Dis­or­der (ADHD) affects about 7% of chil­dren, with a two out of three chance of per­sist­ing into adult­hood. This neu­rode­vel­op­men­tal dis­or­der is char­ac­terised by con­cen­tra­tion dif­fi­cul­ties, increased dis­tractibil­i­ty, impul­siv­i­ty and hyper­ac­tiv­i­ty. Today, ADHD is treat­ed with phar­ma­ceu­ti­cal drugs that may have unwant­ed side effects. This is why sci­en­tists from the Uni­ver­si­ty of Gene­va (UNIGE) and the Uni­ver­si­ty Hos­pi­tals of Gene­va (HUG), Switzer­land, explored a new tech­nique called ‘neu­ro­feed­back’, which enables ADHD patients to train their atten­tion, based on instant feed­back from the lev­el of their brain activ­i­ty. [Read more…] about Study shows promis­ing results of EEG-based brain train­ing in help­ing adults with ADHD

Sneak preview into the future of mental health: Fully digital clinical trials to study digital therapeutics

by

digitaltrial——–

Click Ther­a­peu­tics™ Reports Pre­lim­i­nary Results of a 416-Par­tic­i­pant Clin­i­cal Study Demon­strat­ing Excep­tion­al Engage­ment and Effi­ca­cy of Click­o­tine®, a Patent-Pend­ing Dig­i­tal Ther­a­peu­tics™ Pro­gram for Smok­ing Ces­sa­tion (press release):

“Click Ther­a­peu­tics, Inc. (“Click”), a com­pa­ny devel­op­ing a suite of per­son­al­ized data-dri­ven dig­i­tal ther­a­peu­tics for chron­ic health con­di­tions, announces today pre­lim­i­nary results of its ful­ly remote clin­i­cal tri­al of Click­o­tine, a dig­i­tal pro­gram designed for smok­ing ces­sa­tion. [Read more…] about Sneak pre­view into the future of men­tal health: Ful­ly dig­i­tal clin­i­cal tri­als to study dig­i­tal therapeutics

Next: FDA-cleared mobile brain monitoring tools to detect cognitive impairment

by

neuronetrix

___________

FDA Has Cleared New Cog­ni­tive Screen­ing Tests (Alz­fo­rum):

“The Food and Drug Admin­is­tra­tion recent­ly cleared, mean­ing it deemed safe, two tests that may help doc­tors screen for cog­ni­tive decline. One is the so-called Cog­ni­sion sys­tem from Neu­ronetrix, a com­pa­ny based in [Read more…] about Next: FDA-cleared mobile brain mon­i­tor­ing tools to detect cog­ni­tive impairment

January Update: The Federal Trade Commission orders Focus Education to stop making unsubstantiated brain training claims

by

brain-activity.

Time for Sharp­Brains’ Jan­u­ary e‑newsletter, fea­tur­ing a wealth of brain health insights, neu­ro­science research reports, a land­mark action by the Fed­er­al Trade Commission…and some quick brain teasers. Enjoy!

New research:

New think­ing:

New tools:

Final­ly, when you have a few min­utes you may want to try these quick brain teasers to test your cog­ni­tive skills…and your cog­ni­tive bias­es.

Have a great month of February!

FDA clears use of EEG-based ADHD test

by

human-brain-biometricsFirst ADHD brain wave test approved by FDA (CBS News):

“Diag­nos­ing some­one with atten­tion deficit hyper­ac­tiv­i­ty dis­or­der (ADHD) is often a tricky sci­ence because it relies heav­i­ly on psy­chi­atric and behav­ioral exam­i­na­tions. For the first time, the Food and Drug Admin­is­tra­tion has approved a device that [Read more…] about FDA clears use of EEG-based ADHD test

The future of intuitive technology and neurocognitive care?

by

accelespellEnvi­sion­ing The Future With Inven­tor Cori Lath­an (NPR): “Com­put­ers were cre­at­ed to be use­ful tools, but all too often it’s still a chore to get tech­nol­o­gy to do our bidding…For exam­ple, work­ing as an engi­neer with astro­nauts at NASA, Lath­an real­ized that the phys­i­cal chal­lenges of liv­ing in space in some ways mir­ror the chal­lenges of liv­ing with a dis­abil­i­ty on Earth. [Read more…] about The future of intu­itive tech­nol­o­gy and neu­rocog­ni­tive care?